Bio-Rad Laboratories Class A
232 hedge funds and large institutions have $2.53B invested in Bio-Rad Laboratories Class A in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 97 increasing their positions, 72 reducing their positions, and 29 closing their positions.
763% more call options, than puts
Call options by funds: $6.02M | Put options by funds: $697K
35% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 72
2% less capital invested
Capital invested by funds: $2.58B → $2.53B (-$48.1M)
1.13% less ownership
Funds ownership: 78.1% → 76.97% (-1.1%)
4% less funds holding
Funds holding: 241 → 232 (-9)
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
+$13.1M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$13M |
| 3 |
Millennium Management
New York
|
+$10.4M |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$9.62M |
| 5 |
Renaissance Technologies
New York
|
+$8.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$24.5M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$17.8M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$13.9M |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$10.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$9.18M |
BIO Hedge Fund Activity: Q1 2016 in Review
232 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2016, worth a combined $2.53B — down 1.9% from $2.58B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of BIO and 22 opened new positions — a net loss of 7 holders — while 72 trimmed existing stakes and 97 added.
The largest buyer was HSBC Holdings, adding an estimated $13.1M. The largest seller was Copper Rock Capital Partners, exiting entirely with an estimated $24.5M sold.
- 232 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2016, down from 241 in Q4 2015.
- Funds reported $2.53B of Bio-Rad Laboratories Class A stock for Q1 2016, down 1.9% quarter-over-quarter.
- 22 funds opened new Bio-Rad Laboratories Class A positions in Q1 2016 and 29 closed out, a net change of -7 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2016 was HSBC Holdings, an estimated $13.1M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2016 was Copper Rock Capital Partners, an estimated $24.5M sold.
Based on aggregated 13F filings for Q1 2016.